Table of Contents 1 Pneumococcal Vaccines Market Overview 1.1 Product Overview and Scope of Pneumococcal Vaccines 1.2 Pneumococcal Vaccines Segment by Type 1.2.1 Global Pneumococcal Vaccines Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 PPSV 23 1.2.3 PCV 7/13 1.2.4 PCV 10 1.3 Pneumococcal Vaccines Segment by Application 1.3.1 Pneumococcal Vaccines Sales Comparison by Application: 2020 VS 2026 1.3.2 For Infants 1.3.3 For Children (2-10) 1.3.4 For Person (10-64) 1.3.5 For The Old (Above 65) 1.4 Global Pneumococcal Vaccines Market Size Estimates and Forecasts 1.4.1 Global Pneumococcal Vaccines Revenue 2015-2026 1.4.2 Global Pneumococcal Vaccines Sales 2015-2026 1.4.3 Pneumococcal Vaccines Market Size by Region: 2020 Versus 2026 2 Global Pneumococcal Vaccines Market Competition by Manufacturers 2.1 Global Pneumococcal Vaccines Sales Market Share by Manufacturers (2015-2020) 2.2 Global Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020) 2.3 Global Pneumococcal Vaccines Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Pneumococcal Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Pneumococcal Vaccines Market Competitive Situation and Trends 2.5.1 Pneumococcal Vaccines Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Pneumococcal Vaccines Players (Opinion Leaders) 3 Pneumococcal Vaccines Retrospective Market Scenario by Region 3.1 Global Pneumococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Pneumococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Pneumococcal Vaccines Market Facts & Figures by Country 3.3.1 North America Pneumococcal Vaccines Sales by Country 3.3.2 North America Pneumococcal Vaccines Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Pneumococcal Vaccines Market Facts & Figures by Country 3.4.1 Europe Pneumococcal Vaccines Sales by Country 3.4.2 Europe Pneumococcal Vaccines Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Pneumococcal Vaccines Sales by Region 3.5.2 Asia Pacific Pneumococcal Vaccines Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Pneumococcal Vaccines Market Facts & Figures by Country 3.6.1 Latin America Pneumococcal Vaccines Sales by Country 3.6.2 Latin America Pneumococcal Vaccines Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Pneumococcal Vaccines Sales by Country 3.7.2 Middle East and Africa Pneumococcal Vaccines Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Pneumococcal Vaccines Historic Market Analysis by Type 4.1 Global Pneumococcal Vaccines Sales Market Share by Type (2015-2020) 4.2 Global Pneumococcal Vaccines Revenue Market Share by Type (2015-2020) 4.3 Global Pneumococcal Vaccines Price Market Share by Type (2015-2020) 4.4 Global Pneumococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Pneumococcal Vaccines Historic Market Analysis by Application 5.1 Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020) 5.2 Global Pneumococcal Vaccines Revenue Market Share by Application (2015-2020) 5.3 Global Pneumococcal Vaccines Price by Application (2015-2020) 6 Company Profiles and Key Figures in Pneumococcal Vaccines Business 6.1 Pfizer 6.1.1 Corporation Information 6.1.2 Pfizer Description, Business Overview and Total Revenue 6.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Pfizer Products Offered 6.1.5 Pfizer Recent Development 6.2 Sanofi 6.2.1 Sanofi Pneumococcal Vaccines Production Sites and Area Served 6.2.2 Sanofi Description, Business Overview and Total Revenue 6.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Sanofi Products Offered 6.2.5 Sanofi Recent Development 6.3 GSK 6.3.1 GSK Pneumococcal Vaccines Production Sites and Area Served 6.3.2 GSK Description, Business Overview and Total Revenue 6.3.3 GSK Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.3.4 GSK Products Offered 6.3.5 GSK Recent Development 6.4 Merck 6.4.1 Merck Pneumococcal Vaccines Production Sites and Area Served 6.4.2 Merck Description, Business Overview and Total Revenue 6.4.3 Merck Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Merck Products Offered 6.4.5 Merck Recent Development 6.5 Eli Lilly 6.5.1 Eli Lilly Pneumococcal Vaccines Production Sites and Area Served 6.5.2 Eli Lilly Description, Business Overview and Total Revenue 6.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Eli Lilly Products Offered 6.5.5 Eli Lilly Recent Development 6.6 AstraZeneca 6.6.1 AstraZeneca Pneumococcal Vaccines Production Sites and Area Served 6.6.2 AstraZeneca Description, Business Overview and Total Revenue 6.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.6.4 AstraZeneca Products Offered 6.6.5 AstraZeneca Recent Development 6.7 Abera 6.6.1 Abera Pneumococcal Vaccines Production Sites and Area Served 6.6.2 Abera Description, Business Overview and Total Revenue 6.6.3 Abera Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Abera Products Offered 6.7.5 Abera Recent Development 6.8 S K Chemicals 6.8.1 S K Chemicals Pneumococcal Vaccines Production Sites and Area Served 6.8.2 S K Chemicals Description, Business Overview and Total Revenue 6.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.8.4 S K Chemicals Products Offered 6.8.5 S K Chemicals Recent Development 6.9 Beijing Minhai Biotechnology 6.9.1 Beijing Minhai Biotechnology Pneumococcal Vaccines Production Sites and Area Served 6.9.2 Beijing Minhai Biotechnology Description, Business Overview and Total Revenue 6.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Beijing Minhai Biotechnology Products Offered 6.9.5 Beijing Minhai Biotechnology Recent Development 6.10 Baxter 6.10.1 Baxter Pneumococcal Vaccines Production Sites and Area Served 6.10.2 Baxter Description, Business Overview and Total Revenue 6.10.3 Baxter Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Baxter Products Offered 6.10.5 Baxter Recent Development 6.11 Biken 6.11.1 Biken Pneumococcal Vaccines Production Sites and Area Served 6.11.2 Biken Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.11.3 Biken Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Biken Products Offered 6.11.5 Biken Recent Development 6.12 Celgene Corporation 6.12.1 Celgene Corporation Pneumococcal Vaccines Production Sites and Area Served 6.12.2 Celgene Corporation Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.12.3 Celgene Corporation Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Celgene Corporation Products Offered 6.12.5 Celgene Corporation Recent Development 6.13 Panacea Biotec 6.13.1 Panacea Biotec Pneumococcal Vaccines Production Sites and Area Served 6.13.2 Panacea Biotec Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.13.3 Panacea Biotec Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Panacea Biotec Products Offered 6.13.5 Panacea Biotec Recent Development 6.14 Serum Institute of India 6.14.1 Serum Institute of India Pneumococcal Vaccines Production Sites and Area Served 6.14.2 Serum Institute of India Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.14.3 Serum Institute of India Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Serum Institute of India Products Offered 6.14.5 Serum Institute of India Recent Development 6.15 Genentech 6.15.1 Genentech Pneumococcal Vaccines Production Sites and Area Served 6.15.2 Genentech Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.15.3 Genentech Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Genentech Products Offered 6.15.5 Genentech Recent Development 6.16 Genocea Biosciences 6.16.1 Genocea Biosciences Pneumococcal Vaccines Production Sites and Area Served 6.16.2 Genocea Biosciences Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.16.3 Genocea Biosciences Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Genocea Biosciences Products Offered 6.16.5 Genocea Biosciences Recent Development 6.17 ImmunoBiology 6.17.1 ImmunoBiology Pneumococcal Vaccines Production Sites and Area Served 6.17.2 ImmunoBiology Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.17.3 ImmunoBiology Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.17.4 ImmunoBiology Products Offered 6.17.5 ImmunoBiology Recent Development 6.18 Lupin 6.18.1 Lupin Pneumococcal Vaccines Production Sites and Area Served 6.18.2 Lupin Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.18.3 Lupin Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Lupin Products Offered 6.18.5 Lupin Recent Development 6.19 Nuron Biotech 6.19.1 Nuron Biotech Pneumococcal Vaccines Production Sites and Area Served 6.19.2 Nuron Biotech Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.19.3 Nuron Biotech Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.19.4 Nuron Biotech Products Offered 6.19.5 Nuron Biotech Recent Development 6.20 Biogen 6.20.1 Biogen Pneumococcal Vaccines Production Sites and Area Served 6.20.2 Biogen Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.20.3 Biogen Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.20.4 Biogen Products Offered 6.20.5 Biogen Recent Development 6.21 Valneva Austria 6.21.1 Valneva Austria Pneumococcal Vaccines Production Sites and Area Served 6.21.2 Valneva Austria Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.21.3 Valneva Austria Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.21.4 Valneva Austria Products Offered 6.21.5 Valneva Austria Recent Development 6.22 Sinovac 6.22.1 Sinovac Pneumococcal Vaccines Production Sites and Area Served 6.22.2 Sinovac Pneumococcal Vaccines Description, Business Overview and Total Revenue 6.22.3 Sinovac Pneumococcal Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.22.4 Sinovac Products Offered 6.22.5 Sinovac Recent Development 7 Pneumococcal Vaccines Manufacturing Cost Analysis 7.1 Pneumococcal Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pneumococcal Vaccines 7.4 Pneumococcal Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pneumococcal Vaccines Distributors List 8.3 Pneumococcal Vaccines Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Pneumococcal Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pneumococcal Vaccines by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Pneumococcal Vaccines by Type (2021-2026) 10.2 Pneumococcal Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pneumococcal Vaccines by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Pneumococcal Vaccines by Application (2021-2026) 10.3 Pneumococcal Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pneumococcal Vaccines by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Pneumococcal Vaccines by Region (2021-2026) 10.4 North America Pneumococcal Vaccines Estimates and Projections (2021-2026) 10.5 Europe Pneumococcal Vaccines Estimates and Projections (2021-2026) 10.6 Asia Pacific Pneumococcal Vaccines Estimates and Projections (2021-2026) 10.7 Latin America Pneumococcal Vaccines Estimates and Projections (2021-2026) 10.8 Middle East and Africa Pneumococcal Vaccines Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Pneumococcal Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Pneumococcal Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Pneumococcal Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Pneumococcal Vaccines Manufacturers Covered in This Study Table 5. Global Pneumococcal Vaccines Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Pneumococcal Vaccines Sales Share by Manufacturers (2015-2020) Table 7. Global Pneumococcal Vaccines Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Pneumococcal Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Pneumococcal Vaccines Sales Sites and Area Served Table 11. Manufacturers Pneumococcal Vaccines Product Types Table 12. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pneumococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccines as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Pneumococcal Vaccines Players Table 16. Global Pneumococcal Vaccines Sales (K Units) by Region (2015-2020) Table 17. Global Pneumococcal Vaccines Sales Market Share by Region (2015-2020) Table 18. Global Pneumococcal Vaccines Revenue (Million US$) by Region (2015-2020) Table 19. Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2020) Table 20. North America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units) Table 21. North America Pneumococcal Vaccines Sales Market Share by Country (2015-2020) Table 22. North America Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million) Table 23. North America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020) Table 24. Europe Pneumococcal Vaccines Sales by Country (2015-2020) (K Units) Table 25. Europe Pneumococcal Vaccines Sales Market Share by Country (2015-2020) Table 26. Europe Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Pneumococcal Vaccines Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Pneumococcal Vaccines Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Pneumococcal Vaccines Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region (2015-2020) Table 32. Latin America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units) Table 33. Latin America Pneumococcal Vaccines Sales Market Share by Country (2015-2020) Table 34. Latin America Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Pneumococcal Vaccines Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country (2015-2020) Table 40. Global Pneumococcal Vaccines Sales (K Units) by Type (2015-2020) Table 41. Global Pneumococcal Vaccines Sales Share by Type (2015-2020) Table 42. Global Pneumococcal Vaccines Revenue (Million US$) by Type (2015-2020) Table 43. Global Pneumococcal Vaccines Revenue Share by Type (2015-2020) Table 44. Global Pneumococcal Vaccines Price (USD/Unit) by Type (2015-2020) Table 45. Global Pneumococcal Vaccines Sales (K Units) by Application (2015-2020) Table 46. Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020) Table 47. Global Pneumococcal Vaccines Sales Growth Rate by Application (2015-2020) Table 48. Pfizer Pneumococcal Vaccines Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Pfizer Main Product Table 52. Pfizer Recent Development Table 53. Sanofi Pneumococcal Vaccines Corporation Information Table 54. Sanofi Corporation Information Table 55. Sanofi Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Sanofi Main Product Table 57. Sanofi Recent Development Table 58. GSK Pneumococcal Vaccines Corporation Information Table 59. GSK Corporation Information Table 60. GSK Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. GSK Main Product Table 62. GSK Recent Development Table 63. Merck Pneumococcal Vaccines Corporation Information Table 64. Merck Corporation Information Table 65. Merck Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Merck Main Product Table 67. Merck Recent Development Table 68. Eli Lilly Pneumococcal Vaccines Corporation Information Table 69. Eli Lilly Corporation Information Table 70. Eli Lilly Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Eli Lilly Main Product Table 72. Eli Lilly Recent Development Table 73. AstraZeneca Pneumococcal Vaccines Corporation Information Table 74. AstraZeneca Corporation Information Table 75. AstraZeneca Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. AstraZeneca Main Product Table 77. AstraZeneca Recent Development Table 78. Abera Pneumococcal Vaccines Corporation Information Table 79. Abera Corporation Information Table 80. Abera Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Abera Main Product Table 82. Abera Recent Development Table 83. S K Chemicals Pneumococcal Vaccines Corporation Information Table 84. S K Chemicals Corporation Information Table 85. S K Chemicals Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. S K Chemicals Main Product Table 87. S K Chemicals Recent Development Table 88. Beijing Minhai Biotechnology Pneumococcal Vaccines Corporation Information Table 89. Beijing Minhai Biotechnology Corporation Information Table 90. Beijing Minhai Biotechnology Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Beijing Minhai Biotechnology Main Product Table 92. Beijing Minhai Biotechnology Recent Development Table 93. Baxter Pneumococcal Vaccines Corporation Information Table 94. Baxter Corporation Information Table 95. Baxter Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Baxter Main Product Table 97. Baxter Recent Development Table 98. Biken Pneumococcal Vaccines Corporation Information Table 99. Biken Corporation Information Table 100. Biken Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 101. Biken Main Product Table 102. Biken Recent Development Table 103. Celgene Corporation Pneumococcal Vaccines Corporation Information Table 104. Celgene Corporation Corporation Information Table 105. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Celgene Corporation Main Product Table 107. Celgene Corporation Recent Development Table 108. Panacea Biotec Pneumococcal Vaccines Corporation Information Table 109. Panacea Biotec Corporation Information Table 110. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. Panacea Biotec Main Product Table 112. Panacea Biotec Recent Development Table 113. Serum Institute of India Pneumococcal Vaccines Corporation Information Table 114. Serum Institute of India Corporation Information Table 115. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Serum Institute of India Main Product Table 117. Serum Institute of India Recent Development Table 118. Genentech Pneumococcal Vaccines Corporation Information Table 119. Genentech Corporation Information Table 120. Genentech Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Genentech Main Product Table 122. Genentech Recent Development Table 123. Genocea Biosciences Pneumococcal Vaccines Corporation Information Table 124. Genocea Biosciences Corporation Information Table 125. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Genocea Biosciences Main Product Table 127. Genocea Biosciences Recent Development Table 128. ImmunoBiology Pneumococcal Vaccines Corporation Information Table 129. ImmunoBiology Corporation Information Table 130. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. ImmunoBiology Main Product Table 132. ImmunoBiology Recent Development Table 133. Lupin Pneumococcal Vaccines Corporation Information Table 134. Lupin Corporation Information Table 135. Lupin Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Lupin Main Product Table 137. Lupin Recent Development Table 138. Nuron Biotech Pneumococcal Vaccines Corporation Information Table 139. Nuron Biotech Corporation Information Table 140. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. Nuron Biotech Main Product Table 142. Nuron Biotech Recent Development Table 143. Biogen Pneumococcal Vaccines Corporation Information Table 144. Biogen Corporation Information Table 145. Biogen Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 146. Biogen Main Product Table 147. Biogen Recent Development Table 148. Valneva Austria Pneumococcal Vaccines Corporation Information Table 149. Valneva Austria Corporation Information Table 150. Valneva Austria Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 151. Valneva Austria Main Product Table 152. Valneva Austria Recent Development Table 153. Sinovac Pneumococcal Vaccines Corporation Information Table 154. Sinovac Corporation Information Table 155. Sinovac Pneumococcal Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 156. Sinovac Main Product Table 157. Sinovac Recent Development Table 158. Sales Base and Market Concentration Rate of Raw Material Table 159. Key Suppliers of Raw Materials Table 160. Pneumococcal Vaccines Distributors List Table 161. Pneumococcal Vaccines Customers List Table 162. Market Key Trends Table 163. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 164. Key Challenges Table 165. Global Pneumococcal Vaccines Sales (K Units) Forecast by Type (2021-2026) Table 166. Global Pneumococcal Vaccines Sales Market Share Forecast by Type (2021-2026) Table 167. Global Pneumococcal Vaccines Revenue (Million US$) Forecast by Type (2021-2026) Table 168. Global Pneumococcal Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 169. Global Pneumococcal Vaccines Sales (K Units) Forecast by Application (2021-2026) Table 170. Global Pneumococcal Vaccines Revenue (Million US$) Forecast by Application (2021-2026) Table 171. Global Pneumococcal Vaccines Sales (K Units) Forecast by Region (2021-2026) Table 172. Global Pneumococcal Vaccines Sales Market Share Forecast by Region (2021-2026) Table 173. Global Pneumococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 174. Global Pneumococcal Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 175. Research Programs/Design for This Report Table 176. Key Data Information from Secondary Sources Table 177. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Pneumococcal Vaccines Figure 2. Global Pneumococcal Vaccines Sales Market Share by Type: 2020 VS 2026 Figure 3. PPSV 23 Product Picture Figure 4. PCV 7/13 Product Picture Figure 5. PCV 10 Product Picture Figure 6. Global Pneumococcal Vaccines Consumption Market Share by Application: 2020 VS 2026 Figure 7. For Infants Figure 8. For Children (2-10) Figure 9. For Person (10-64) Figure 10. For The Old (Above 65) Figure 11. Global Pneumococcal Vaccines Market Size 2015-2026 (US$ Million) Figure 12. Global Pneumococcal Vaccines Sales Capacity (K Units) (2015-2026) Figure 13. Global Pneumococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Pneumococcal Vaccines Sales Share by Manufacturers in 2020 Figure 15. Global Pneumococcal Vaccines Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Vaccines Revenue in 2019 Figure 17. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Pneumococcal Vaccines Sales Market Share by Region (2015-2020) Figure 19. Global Pneumococcal Vaccines Sales Market Share by Region in 2019 Figure 20. Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2020) Figure 21. Global Pneumococcal Vaccines Revenue Market Share by Region in 2019 Figure 22. North America Pneumococcal Vaccines Sales Market Share by Country in 2019 Figure 23. North America Pneumococcal Vaccines Revenue Market Share by Country in 2019 Figure 24. U.S. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 25. U.S. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 27. Canada Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Pneumococcal Vaccines Sales Market Share by Country in 2019 Figure 29. Europe Pneumococcal Vaccines Revenue Market Share by Country in 2019 Figure 30. Germany Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 31. Germany Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 33. France Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 35. U.K. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 37. Italy Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 39. Russia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region in 2019 Figure 41. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region in 2019 Figure 42. China Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 43. China Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 45. Japan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 47. South Korea Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 49. India Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 51. Australia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 53. Taiwan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 55. Indonesia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 57. Thailand Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 59. Malaysia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 61. Philippines Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 63. Vietnam Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Pneumococcal Vaccines Sales Market Share by Country in 2019 Figure 65. Latin America Pneumococcal Vaccines Revenue Market Share by Country in 2019 Figure 66. Mexico Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 67. Mexico Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 69. Brazil Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 71. Argentina Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country in 2019 Figure 74. Turkey Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 75. Turkey Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 77. Saudi Arabia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units) Figure 79. U.A.E Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Pneumococcal Vaccines by Type (2015-2020) Figure 81. Sales Market Share of Pneumococcal Vaccines by Type in 2019 Figure 82. Revenue Share of Pneumococcal Vaccines by Type (2015-2020) Figure 83. Revenue Market Share of Pneumococcal Vaccines by Type in 2019 Figure 84. Global Pneumococcal Vaccines Sales Growth by Type (2015-2020) (K Units) Figure 85. Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020) Figure 86. Global Pneumococcal Vaccines Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Pneumococcal Vaccines by Application (2015-2020) Figure 88. Global Revenue Share of Pneumococcal Vaccines by Application in 2020 Figure 89. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Abera Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. S K Chemicals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Beijing Minhai Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Biken Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Genentech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Genocea Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. ImmunoBiology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Lupin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Nuron Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Biogen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Valneva Austria Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Price Trend of Key Raw Materials Figure 112. Manufacturing Cost Structure of Pneumococcal Vaccines Figure 113. Manufacturing Process Analysis of Pneumococcal Vaccines Figure 114. Pneumococcal Vaccines Industrial Chain Analysis Figure 115. Channels of Distribution Figure 116. Distributors Profiles Figure 117. Porter's Five Forces Analysis Figure 118. North America Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 119. North America Pneumococcal Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Europe Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 121. Europe Pneumococcal Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Latin America Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 123. Latin America Pneumococcal Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Middle East and Africa Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 125. Middle East and Africa Pneumococcal Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 126. Asia Pacific Pneumococcal Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 127. Asia Pacific Pneumococcal Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 128. Bottom-up and Top-down Approaches for This Report Figure 129. Data Triangulation Figure 130. Key Executives Interviewed

Pfizer Sanofi GSK Merck Eli Lilly AstraZeneca Abera S K Chemicals Beijing Minhai Biotechnology Baxter Biken Celgene Corporation Panacea Biotec Serum Institute of India Genentech Genocea Biosciences ImmunoBiology Lupin Nuron Biotech Biogen Valneva Austria Sinovac